NovoCure (NVCR) Short Interest Ratio & Short Volume → This AI Trade Machine Made 1,729%* (With 89% Wins) (From Prosper Trading Academy) (Ad) Free NVCR Stock Alerts $12.64 +0.40 (+3.27%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability NovoCure Short Interest DataCurrent Short Volume6,040,000 sharesPrevious Short Volume5,010,000 sharesChange Vs. Previous Month+20.56%Dollar Volume Sold Short$76.83 millionShort Interest Ratio / Days to Cover4.8Last Record DateApril 15, 2024Outstanding Shares107,610,000 sharesFloat Size96,280,000 sharesShort Percent of Float6.27%Today's Trading Volume762,109 sharesAverage Trading Volume1,083,416 sharesToday's Volume Vs. Average70% Short Selling NovoCure ? Sign up to receive the latest short interest report for NovoCure and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNVCR Short Interest Over TimeNVCR Days to Cover Over TimeNVCR Percentage of Float Shorted Over Time Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy NovoCure Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20246,040,000 shares $76.83 million +20.6%6.3%4.8 $12.72 3/31/20245,010,000 shares $78.31 million -9.6%5.2%3.6 $15.63 3/15/20245,540,000 shares $77.45 million -1.8%5.8%4.5 $13.98 2/29/20245,640,000 shares $86.35 million -8.0%5.9%4.4 $15.31 2/15/20246,130,000 shares $97.65 million +6.2%6.3%4.6 $15.93 1/31/20245,770,000 shares $80.32 million -17.0%6.0%4.2 $13.92 Get the Latest News and Ratings for NVCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NovoCure and its competitors with MarketBeat's FREE daily newsletter. 1/15/20246,950,000 shares $93.06 million +0.3%7.2%4.8 $13.39 12/31/20236,930,000 shares $103.46 million -2.8%7.2%5 $14.93 12/15/20237,130,000 shares $96.68 million -10.5%7.4%5 $13.56 11/30/20237,970,000 shares $97.79 million -5.0%8.3%5.5 $12.27 11/15/20238,390,000 shares $106.39 million -6.1%8.7%4.5 $12.68 10/31/20238,930,000 shares $118.77 million +6.3%9.2%4.8 $13.30 10/15/20238,400,000 shares $119.36 million +2.8%8.7%4.5 $14.21 9/30/20238,170,000 shares $131.95 million +7.8%8.5%4.2 $16.15 9/15/20237,580,000 shares $146.29 million -17.7%7.9%4.3 $19.30 8/31/20239,210,000 shares $203.17 million -1.8%9.6%5 $22.06 8/15/20239,380,000 shares $293.59 million +5.9%9.7%5.7 $31.30 7/31/20238,860,000 shares $289.19 million -0.2%N/A5.7 $32.64 7/15/20238,880,000 shares $354.67 million +2.0%N/A6.4 $39.94 6/30/20238,710,000 shares $361.47 million +3.7%N/A6.9 $41.50 6/15/20238,400,000 shares $368.76 million +4.0%N/A6.9 $43.90 5/31/20238,080,000 shares $580.22 million -1.2%N/A7.5 $71.81 5/15/20238,180,000 shares $636.57 million +5.8%N/A12.4 $77.82 4/30/20237,730,000 shares $509.41 million -1.9%N/A12.1 $65.90 4/15/20237,880,000 shares $494.23 million +2.1%7.6%12 $62.72 3/31/20237,720,000 shares $464.28 million -3.3%7.5%9.5 $60.14 3/15/20237,980,000 shares $523.17 million -8.4%7.7%7.8 $65.56 2/28/20238,710,000 shares $670.41 million +3.4%N/A9 $76.97 2/15/20238,420,000 shares $740.71 million +4.5%8.2%8.8 $87.97 1/31/20238,060,000 shares $734.91 million +3.9%7.8%8.5 $91.18 1/15/20237,760,000 shares $729.36 million -2.4%7.5%8.4 $93.99 12/30/20227,950,000 shares $583.13 million +2.3%7.7%9.4 $73.35 12/15/20227,770,000 shares $579.56 million -4.0%7.5%14.8 $74.59 11/30/20228,090,000 shares $621.64 million -1.3%7.9%16.6 $76.84 11/15/20228,200,000 shares $688.80 million -1.2%8.0%17.6 $84.00 10/31/20228,300,000 shares $586.48 million +4.3%8.1%18.2 $70.66 10/15/20227,960,000 shares $582.11 million +5.4%7.7%16.5 $73.13 9/30/20227,550,000 shares $573.65 million +0.3%7.3%16.7 $75.98 9/15/20227,530,000 shares $669.79 million +2.9%7.3%16 $88.95 8/31/20227,320,000 shares $601.19 million +5.5%7.1%12.9 $82.13These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy NVCR Short Interest - Frequently Asked Questions What is NovoCure's current short interest? Short interest is the volume of NovoCure shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 6,040,000 shares of NVCR short. 6.27% of NovoCure's shares are currently sold short. Learn More on NovoCure's current short interest. What is a good short interest ratio for NovoCure? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NVCR shares currently have a short interest ratio of 5.0. Learn More on NovoCure's short interest ratio. Which institutional investors are shorting NovoCure? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of NovoCure: Simplex Trading LLC, BNP Paribas Financial Markets, Simplex Trading LLC, and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for NovoCure? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.27% of NovoCure's floating shares are currently sold short. Is NovoCure's short interest increasing or decreasing? NovoCure saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 6,040,000 shares, an increase of 20.6% from the previous total of 5,010,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is NovoCure's float size? NovoCure currently has issued a total of 107,610,000 shares. Some of NovoCure's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NovoCure currently has a public float of 96,280,000 shares. How does NovoCure's short interest compare to its competitors? 6.27% of NovoCure's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to NovoCure: LeMaitre Vascular, Inc. (4.25%), AtriCure, Inc. (6.61%), MiMedx Group, Inc. (3.73%), Artivion, Inc. (7.16%), Paragon 28, Inc. (9.33%), Alphatec Holdings, Inc. (8.76%), OrthoPediatrics Corp. (6.10%), Atrion Co. (8.72%), Silk Road Medical, Inc (10.57%), Treace Medical Concepts, Inc. (6.39%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short NovoCure stock? Short selling NVCR is an investing strategy that aims to generate trading profit from NovoCure as its price is falling. NVCR shares are trading up $0.40 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NovoCure? A short squeeze for NovoCure occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NVCR, which in turn drives the price of the stock up even further. How often is NovoCure's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NVCR, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: LMAT Short Interest Data ATRC Short Interest Data MDXG Short Interest Data AORT Short Interest Data FNA Short Interest Data ATEC Short Interest Data KIDS Short Interest Data ATRI Short Interest Data SILK Short Interest Data TMCI Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NVCR) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace